Clinical utility of triptans in the management of headache attributed to dural arteriovenous fistula involving the cavernous sinus

J Neurol Sci. 2015 Feb 15;349(1-2):260-1. doi: 10.1016/j.jns.2015.01.011. Epub 2015 Jan 12.

Authors

Mayuko Osaka¹, Mamoru Shibata², Koichi Oki¹, Satoshi Yamada³, Kenji Kufukihara¹, Takenori Akiyama⁴, Kazunari Yoshida⁴, Norihiro Suzuki¹

Affiliations

¹ Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
² Department of Neurology, Keio University School of Medicine, Tokyo, Japan. Electronic address: mshibata@a7.keio.jp.
³ Department of Neurology, Saiseikai Central Hospital, Tokyo, Japan.
⁴ Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan.

PMID: 25601770
DOI: 10.1016/j.jns.2015.01.011

No abstract available

Keywords: Cavernous sinus; Dural arteriovenous fistula; Headache; Paradoxical worsening; Pregabalin; Triptans.

Publication types

Case Reports
Letter

MeSH terms

Aged
Cavernous Sinus / pathology*
Central Nervous System Vascular Malformations / pathology*
Female
Headache / drug therapy*
Headache / etiology*
Headache / pathology
Humans
Tryptamines / therapeutic use*

Substances

Tryptamines